Athenex, Inc. (ATNXQ)
Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.
Address
1001 MAIN STREET
BUFFALO, NY 14203
Founded
2003
Number of Employees
280
Website
http://www.athenex.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)